COMP <GO>
TRN vs TMO // EV/EBITDA & P/E VALUATION
Trinity Industries Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: TRN 7
— TMO 5
▲ EV/EBITDA & P/E VALUATION LEADER: TRN
LAST: $28.32 (+10.80%) • MKT CAP: $2.26B
valuation
3.0x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
valuation
30.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRN VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TRN | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 58.60% | 9.30% | +49.30 | TRN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 3.0x | 30.4x | -27.40 | TRN | /valuation <GO> |
| Free Cash Flow Yield | 13.92% | 2.40% | +11.52 | TRN | /fcf-yield <GO> |
| Operating Margin | 30.10% | 17.40% | +12.70 | TRN | /operating-margins <GO> |
| Net Profit Margin | 12.90% | 15.10% | -2.20 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -30.00% | 3.90% | -33.90 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.37% | 0.24% | +4.13 | TRN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.88 | 4.50 | -3.62 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 70.9 | 62.9 | +8.01 | TRN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 7.5x | 36.3x | -28.80 | TRN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.26B | $262.22B | -$259.96B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TRN REV | TMO REV | TRN GROSS % | TMO GROSS % | TRN FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.16B | $44.56B | — | — | $314.1M | $6.29B |
| FY 2024 | $3.08B | $42.88B | 21.7% | — | $520.0M | $7.27B |
| FY 2023 | $2.98B | $42.86B | — | — | $295.6M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRN // BETA —
TMO // BETA 0.94